课题基金 / 基金详情

Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti

Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti
神经影像学评估急性淋巴细胞白血病儿童的治疗效果
批准号:
7747068
负责人:
THOMAS M ERNST
金额:
$30.45万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-20 至 2011-05-31
关键词:
6 year oldAcuteAcute Lymphocytic LeukemiaAcute T Cell LeukemiaAffectAftercareAgeAnisotropyArtsAttention ConcentrationBasal GangliaBiological AssayBiological MarkersBrainBrain InjuriesBrain regionCerebrospinal FluidChemicalsChemistryChildChildren&aposs Oncology GroupCholineClinicalClinical ProtocolsClonal Immunoglobulin Heavy Chain Gene RearrangementCognitiveCognitive deficitsConscious SedationDataDevelopmentDiagnosisDiffusionDiffusion Magnetic Resonance ImagingDiseaseEarly DiagnosisFutureGlutamatesGlutamineGoalsGrowth and Development functionImageImpaired cognitionInstitutesInterventionKnowledgeLeadLearningLeukemia Acute Lymphoblastic ChemotherapyLeukemic CellLifeLongitudinal StudiesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasurementMeasuresMedical centerMemoryMetabolismMicroscopicMinorMitochondrial DNAModalityMolecularMonitorMorbidity - disease rateMotionN-acetylaspartateNervous system structureNeuraxisNeurocognitionNeurocognitiveNeurocognitive DeficitNeuronal InjuryNeuronsPerformancePhenotypeProcessProtocols documentationProtonsReportingResearchResidual NeoplasmResolutionRiskScanningSchoolsSedation procedureSystemTechniquesTest ResultTherapeuticTimeToxic effectWaterX-Ray Computed Tomographycancer cellcentral nervous system injurychemotherapycognitive functiondisorder riskfrontal lobehigh riskimprovedin vivoinnovationmyoinositolneurocognitive testneuroimagingoutcome forecastperformance testspreventpublic health relevanceresponsetoolwater diffusionwhite matter

项目摘要

项目成果

THOMAS M ERNST的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):急性淋巴细胞白血病(ALL)儿童的预后相对较好,但治疗可能对生长和发育产生巨大影响,包括对中枢神经系统(CNS)的影响。这反过来会影响学习成绩和神经认知功能,但ALL治疗和认知缺陷之间的关系还不清楚。由于确诊为ALL的儿童通常会立即开始治疗,因此在治疗前通常很难评估认知功能。如果在以后的生活中发现神经认知缺陷,则不清楚是否发生了治疗相关的CNS损伤,并且通常为时已晚,无法进行适当的干预。该提案旨在评估CNS结构和化学;以及治疗开始后(<6周)和12个月后的认知表现。该研究填补了儿童肿瘤组(COG; www.childrensoncologygroup.org)当前研究的空白,AALL 06 N1(ALL治疗儿童的神经认知功能研究),这是一项针对高风险B谱系和T细胞ALL儿童的研究,但研究排除了患有标准和中等风险ALL的ALL幼儿(3-6岁)。因此,拟议的项目通过研究具有CNS毒性风险的标准和中等风险疾病的3-6岁ALL儿童弥合了一个重要的差距。使用高分辨率结构MRI(HRS-MRI)、磁共振波谱(MRS)和扩散张量成像(DTI)可以在检测异常认知功能之前检测CNS结构和代谢的早期变化。由琳达昌和托马斯恩斯特博士领导的研究正在3-6岁患有其他疾病的儿童中成功进行,使用非侵入性先进MR技术,包括HRS-MRI,MRS和DTI,而无清醒镇静,这在这个年龄段很重要。我们的目标是确定ALL儿童早期结构、化学和功能性CNS变化,长期目标是制定干预措施,以预防晚期神经认知后遗症并改善预后。我们的目标是:1)使用高分辨率MRI、质子MRS和DTI在开始化疗后6周内和初始扫描后12个月确定化疗对ALL儿童大脑的影响; 2)描述基线和12个月时ALL儿童化疗暴露的神经认知功能变化; 3)评估MR扫描异常与神经认知测试中识别的认知缺陷的关系; 4)测量儿童线粒体DNA水平,并评估其与微小残留病、神经认知测试和脑代谢物水平的相关性。意义在于使用敏感的工具(MRS和DTI)的潜力,以检测认知异常之前的早期中枢神经系统的变化被注意到,并可能改善儿童的发病率,否则是不符合开放COG研究。该提案具有创新性,因为该项目利用Ernst和Chang博士在神经成像领域的专业知识,在不使用镇静剂的情况下从幼儿身上获取数据,以进一步了解化疗对大脑发育的影响。公共卫生相关性:诊断为急性淋巴细胞白血病(ALL)的儿童预后相对较好,但治疗可能会影响儿童未来的生长和发育,包括对中枢神经系统(CNS)的影响。该提案旨在评估诊断为标准和中等风险ALL的ALL儿童(3-6岁)在治疗开始后(<6周)和12个月后的CNS结构和化学以及认知表现。
英文摘要
DESCRIPTION (provided by applicant): Children with acute lymphoblastic leukemia (ALL) have a relatively good prognosis, but treatment can have tremendous impacts on growth and development, including effects on the central nervous system (CNS). This in turn affects school performance and neurocognitive function, but the relationship between ALL therapy and cognitive deficits is not well understood. Because children diagnosed with ALL typically begin treatment immediately, it is often difficult to evaluate cognitive function prior to therapy. If neurocognitive deficits are recognized later in life, it is unclear if therapy-associated CNS injury occurred, and often too late to institute appropriate interventions. This proposal aims to evaluate CNS structure and chemistry; and cognitive performance, after therapy begins (<6 weeks), and 12 months later. The study fills a void of a current study in the Children's Oncology Group (COG; www.childrensoncologygroup.org), AALL06N1 (Study of Neurocognitive Function in Children Treated for ALL), which is a study for children with high-risk B- lineage and T-cell ALL, but young children (3-6 year old) with ALL with standard- and intermediate-risk ALL are excluded from the study. Therefore, the proposed project bridges an important gap by studying 3-6 year old children with ALL with standard- and intermediate-risk disease who are at risk for CNS toxicity. Use of high resolution structural MRI (HRS-MRI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI) may allow detection of early changes in CNS structure and metabolism prior to detecting abnormal cognitive function. Studies led by Drs. Linda Chang and Thomas Ernst are successfully being conducted in 3-6 year old children with other diseases, using non-invasive advanced MR techniques, including HRS-MRI, MRS, and DTI without conscious sedation, which is important in this age. Our goal is to identify early structural, chemical, and functional CNS changes in children with ALL with the long term objectives to develop interventions to prevent late neurocognitive sequelae and improve prognosis. Our Aims are: 1) To determine the effect of chemotherapy on the brain in children with ALL using high resolution MRI, proton MRS, and DTI within 6 weeks of starting chemotherapy and at 12 months after the initial scans; 2) To characterize changes in neurocognitive function from chemotherapy exposure in children with ALL at baseline and at 12-months; 3) To assess the relationship of abnormalities on MR scans with cognitive deficits identified from neurocognitive tests; and 4) To measure mitochondrial DNA levels in children and evaluate its association with minimal residual disease, neurocognitive testing, and brain metabolite levels. The significance lies in the potential of using sensitive tools (MRS and DTI) to detect early CNS changes before cognitive abnormalities are noted; and possibly improve morbidity in children who otherwise are not eligible for the open COG study. The proposal is innovative because the project utilizes expertise of Drs. Ernst and Chang in the field of neuroimaging to capture data from young children without the use of sedation to further our understanding of chemotherapy effects on developing brains. PUBLIC HEALTH RELEVANCE: Children diagnosed with acute lymphoblastic leukemia (ALL) have a relatively good prognosis, however treatment can impact a child's future growth and development, including effects on the central nervous system (CNS). This proposal aims to evaluate CNS structure and chemistry; and cognitive performance, after treatment begins (<6 weeks), and 12 months later in children (3-6 year old) with ALL diagnosed with standard- and intermediate-risk ALL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Personalized Motion Management for Truly 4D Lung Radiotherapy
  • 批准号:
    10674801
  • 项目类别:
  • 资助金额:
    $60.29万
  • 财政年份:
    2021
  • 负责人:
    THOMAS M ERNST
  • 依托单位:
Body Fat Compartments Imaging
  • 批准号:
    8374258
  • 项目类别:
  • 资助金额:
    $24.95万
  • 财政年份:
    2012
  • 负责人:
    THOMAS M ERNST
  • 依托单位:
RGR-based motion tracking for real-time adaptive MR imaging and spectroscopy
  • 批准号:
    8473565
  • 项目类别:
  • 资助金额:
    $90.0万
  • 财政年份:
    2012
  • 负责人:
    THOMAS M ERNST
  • 依托单位:
ACTIVITY 1: BIOMEDICAL IMAGING AND BIOENGINEERING
  • 批准号:
    8357169
  • 项目类别:
  • 资助金额:
    $14.53万
  • 财政年份:
    2011
  • 负责人:
    THOMAS M ERNST
  • 依托单位:
海外基金